Alemtuzumab-induced elimination of HIV-1-infected immune cells

BACKGROUND: : Currently, there is no drug known that is able to eradicate either HIV or HIV-infected host cells. The effectiveness of all available treatments is based on the prevention of viral replication. We investigated whether the monoclonal, CD52 receptor-targeting antibody, alemtuzumab, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruxrungtham, Kiat, Sirivichayakul, Sunee, Buranapraditkun, Supranee, Krause, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946689/
https://www.ncbi.nlm.nih.gov/pubmed/27482429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946689/
https://www.ncbi.nlm.nih.gov/pubmed/27482429

Ejemplares similares